Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Interpharm Holdings

1984 FOUNDED
PUBLIC STATUS
501-600 EMPLOYEES
IPAH STOCK SYMBOL
1 INVESTMENTS
Description

Interpharm Holdings Inc manufactures generic and over-the-counter medications. The company also pursues the development of other generic drugs in broad categories.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Stock Exchange
GREY
Primary Office
  • 75 Adams Avenue
  • New York, NY 11788
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Interpharm Holdings’s full profile, request a free trial.

Interpharm Holdings Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
6.92K

Interpharm Holdings Financials Summary

In Thousands,
USD
TTM
31-Dec-2007
FY 2007
30-Jun-2007
FY 2006
30-Jun-2006
FY 2005
30-Jun-2005
Enterprise Value 86,355 117,949 67,925 48,896
Revenue 69,211 75,587 63,355 39,911
EBITDA (18,916) (11,314) (3,956) 1,026
Net Income (29,357) (14,058) (3,790) (149)
Total Assets 64,335 74,374 62,867 46,390
Total Debt 38,471 26,545 15,638 17,031
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Interpharm Holdings Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Interpharm Holdings‘s full profile, request access.

Request full access to PitchBook

Interpharm Holdings Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000 30-May-2003 000000000000000000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Interpharm Holdings Executive Team (1)

Name Title Board
Seat
Contact
Info
Cameron Reid Chief Executive Officer